Previous Article | Next Article 
Journal of Clinical Microbiology, July 2000, p. 2760-2762, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immunoglobulin A1 Protease Activity in
Gemella haemolysans
Jeanet A.
Lomholt and
Mogens
Kilian*
Department of Medical Microbiology and
Immunology, University of Aarhus, DK-8000 Aarhus C, Denmark
Received 29 February 2000/Returned for modification 31 March
2000/Accepted 25 April 2000
 |
ABSTRACT |
The purpose of this study was to determine the occurrence and
nature of immunoglobulin A1 (IgA1) protease activity in members of the
genus Gemella and related taxa. Among a total of 22 Gemella strains belonging to the four species Gemella
haemolysans, Gemella morbillorum, Gemella
sanguinis, and Gemella bergeriae and four reference
strains of the species Helcococcus kunzii, Facklamia hominis, and Globicatella sanguinis, IgA1 protease
activity was an exclusive character of all nine isolates of G. haemolysans. The IgA1 protease of G. haemolysans
appears to be a metallo-type IgA1 protease that cleaves the
Pro227-Thr228 peptide bond in the hinge region
of the
1 chain like that of several Streptococcus species. Phenotypic characterization of the isolates demonstrates that
screening for IgA1 protease activity provides a valuable means for
species differentiation in this group of bacteria.
 |
TEXT |
The genus Gemella
currently comprises the species G. haemolysans, G. morbillorum, G. bergeriae, and G. sanguinis
(2-4). While there is limited information on the natural
occurrence of G. bergeriae and G. sanguinis, both
G. haemolysans and G. morbillorum are part of the
human resident microbiota of several mucosal surfaces (1, 4). Both species have been detected in the oropharynx, and G. morbillorum has, in addition, been detected in the
gastrointestinal tract. The clinical significance of Gemella
species is not entirely clear, though all four species have been
isolated from blood of patients with subacute endocarditis. In
addition, G. haemolysans and G. morbillorum have
been cultured from cerebrospinal fluid of patients with meningitis and
from infected eyes, G. haemolysans has been cultured from
urine, and G. morbillorum has been cultured from bone and
synovial fluid in a patient with septic arthritis (1-4).
Identification of Gemella isolates is notoriously difficult
because of the easy decolorization in the Gram stain, the low growth
rate, and the still not well defined biochemical characteristics of the
individual species. This problem has been enhanced by the recognition
of several related genera of gram-positive cocci, mainly based on
distinct 16S rRNA sequences.
Members of the genus Gemella share many physiologic and
biochemical properties with the viridans group streptococci, including the range of infections that they cause (4). Several
commensal Streptococcus species, i.e., Streptococcus
sanguis, Streptococcus oralis, Streptococcus
mitis biovar 1, and important mucosal pathogens such as
Neisseria meningitidis, Neisseria gonorrhoeae,
Haemophilus influenzae, and Streptococcus
pneumoniae have evolved specific immunoglobulin A1 (IgA1)
proteases. By cleaving human IgA1 in the hinge region into monomeric
Fab fragments that are capable of antigen binding but devoid of
antibody effector functions, these proteases allow bacteria to evade
the protective functions of the principal adaptive immune factor at
mucosal surfaces (6, 10). A previous comprehensive screening
of bacteria revealed IgA1-cleaving activity in two strains of G. haemolysans (7). However, apart from this preliminary
observation, the occurrence and nature of this enzyme activity in
members of the genus Gemella as presently defined and in
more recently described, related taxa have never been examined.
Twenty-two Gemella strains originally isolated from humans
were included in the study. Of these 19 were obtained from the Culture
Collection of the University of Göteborg, Göteborg, Sweden: G. haemolysans strains CCUG 411, CCUG 4815, CCUG 28134, CCUG 33602, CCUG 37278, and CCUG 37985T;
G. sanguinis strains CCUG 37820T, CCUG 24073, CCUG 37821, and CCUG 37970; G. morbillorum strains CCUG 15561, CCUG 18164T, CCUG 18165, CCUG 32414, and
CCUG 32957B; G. bergeriae strains CCUG 31456, CCUG
37817T, CCUG 37818, and CCUG 37968. An additional three
dental plaque isolates of G. haemolysans were from our own
collection (SK940, SK912, and SK891). The identity of the final three
isolates was verified by 16S rRNA gene sequence analysis
(9). In addition, reference strains of the related
catalase-negative, gram-positive cocci Globicatella
sanguinis (strains CCUG 33367 and CCUG 36563), Helcococcus
kunzii (strain CCUG 32213T), and Facklamia
hominis (strain CCUG 36813T), were examined. S. sanguis strain SK1, Streptococcus pneumoniae strain
1416-93, and isolated IgA1 proteases of H. influenzae
strains HK393 (cleavage type 1) and HK224 (cleavage type 2) served as references of different IgA1 protease cleavage specificities.
All strains of gram-positive cocci were propagated on 5% horse blood
agar incubated in air plus 5% CO2 and were biochemically characterized using the API-ZYM system (API bioMérieux, Marcy l'Etoile, France) supplemented with tests for pyrrolidonyl
aminopeptidase activity, acetoin production (Voges-Proskauer [VP]
test), and neuraminidase activity. Acid production from raffinose,
mannitol, sorbitol, sucrose, lactose, maltose, and trehalose was
examined in fluid medium. All tests were performed as previously
described (8). IgA1 protease activity was detected by
suspending several colonies of each strain in 100 µl of substrate
solution containing 2.1 µg of myeloma IgA1 or IgA2m(1) in
phosphate-buffered saline (PBS). After incubation for 20 h at
37°C bacteria were removed by centrifugation at 10,000 × G for 10 min, after which the supernatant was boiled for 5 min
with reducing sample buffer before electrophoresis on a sodium dodecyl
sulfate (SDS)-polyacrylamide gradient (4 to 20%) gel. Protein bands
were visualized using 0.1% (wt/vol) Coomassie blue.
IgA1 protease activity was exclusively detected among the nine
reference strains of G. haemolysans, including the type
strain. Cleavage of IgA2m(1) was not observed for any of the bacterial strains. As illustrated in Fig. 1,
SDS-polyacrylamide gel electrophoresis showed Fc
and
Fd
fragments generated by the IgA1 protease of G. haemolysans that were indistinguishable from those produced by the
S. sanguis IgA1 protease, suggesting the site of cleavage in
the IgA1 hinge region is the peptide bond
Pro227-Thr228, which is the target for the
streptococcal enzyme. The similarity between IgA1 proteases of these
species is further supported by the demonstrated inhibition of the
G. haemolysans IgA1 protease by the metal chelator EDTA,
which corresponds to a metallo-type proteinase (5).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
SDS-polyacrylamide gel electrophoresis of human IgA1 and
IgA2 myeloma proteins before and after incubation for 24 h with
G. haemolysans or reference IgA1 proteases. Lane 1, molecular weight standards (in thousands); lane 2, intact IgA1 control;
lane 3, IgA1 incubated with G. haemolysans cells; lane 4, PBS incubated with G. haemolysans cells; lane 5, IgA1
incubated with S. pneumoniae cells; lane 6, PBS incubated
with S. pneumoniae cells; lane 7, IgA1 incubated with
S. sanguis cells; lane 8, IgA1 incubated with cleavage type
1 IgA1 protease from H. influenzae HK393; lane 9, IgA1
incubated with cleavage type 2 IgA1 protease from H. influenzae HK224; lane 10, IgA1 incubated with G. haemolysans cells in the presence of 100 mM EDTA; lane 11, IgA1
incubated with S. pneumoniae cells in the presence of 100 mM
EDTA; lane 12, IgA2 incubated with G. haemolysans cells;
lane 13, IgA2 incubated with S. pneumoniae cells and 100 mM
EDTA; lane 14, intact IgA2; lane 15, molecular weight standards. Lane 3 demonstrates that G. haemolysans cleaves IgA1 to yield Fc
and Fd fragments identical in size to those released by S. sanguis (lane 7) and distinct from those released by S. pneumoniae (lane 5) and the two cleavage types of H. influenzae (lanes 8 and 9). Note that Fd fragments released by the
protease activity of G. haemolysans and S. sanguis are close to the size of IgA1 light chains (L chain). The
activity is inhibited by EDTA (lane 10). The distinct size of Fc
fragments released from IgA1 by S. pneumoniae (lane 5),
although cleaving the same peptide bond as S. sanguis, is
due to glycosidase activities releasing carbohydrate side chains of the
heavy chain (8). None of the bacteria cleave IgA2 (lanes 12 and 13).
|
|
All strains of the four Gemella species were
alpha-hemolytic, produced acid in glucose broth, and were positive for
esterase lipase C8, naphthol-AS-BI-phosphohydrolase, and pyrrolidonyl
aminopeptidase activity, with the exception of G. haemolysans strain SK891. None of the isolates were positive for
valine arylamidase, trypsin,
-galactosidase,
-galactosidase,
-glucoronidase,
-glucosidase,
-glucosidase,
N-acetyl-
-glucosaminidase,
-mannosidase,
-fucosidase, or neuraminidase. Other biochemical activities are
summarized in Table 1. As illustrated by
the table, G. haemolysans could be distinguished from all
other species by the ability to cleave IgA1. Most of the biochemical
results shown in Table 1 are in agreement with those of other studies
(1, 4). However, some reactions are at variance with those
reported by Collins et al. (2, 3), in spite of the fact that
the majority of strains are common to the two studies. While eight of
nine strains of G. haemolysans examined by us were positive
in the VP test in agreement with results reported by Berger
(1), Collins and coworkers (3) reported this
reaction to be negative. Interestingly, the one negative exception in
our study was the type strain. Likewise, Collins et al. reported no
acid production from sorbitol by G. bergeriae, while three
of four strains were positive in our study, and no acid production by
G. sanguinis from raffinose, while three of four strains
were positive in our study. These discrepant results are likely to be
due to different methods (conventional tube fermentation tests in this
study in contrast to dehydrated substrates in commercial kits in the
study reported by Collins et al. [2, 3]) and emphasize
the problems associated with phenotypic differentiation of members of
this group of bacteria. Thus, the test for IgA1 protease activity is a
valuable differential test for G. haemolysans and G. morbillorum as it is for differentiation of some of species of the
mitis group of streptococci (8).
Although phylogenetically related, members of the genus
Gemella constitute a distinct branch separate from the genus
Streptococcus (12). The finding that their IgA1
proteases are metallo-proteinases and appear to cleave the same peptide
bond shows that they belong to the same family of IgA1 proteases.
Although genetic studies are required to elucidate this question, it is
conceivable that the gene encoding IgA1 protease in G. haemolysans shares a common ancestor with the mutually related
iga genes of S. sanguis, S. oralis,
S. mitis, and S. pneumoniae (11).
Although IgA1 protease enables bacteria to evade the
adherence-inhibitory activity of secretory IgA in vitro and is assumed
to constitute an important virulence determinant in bacterial
meningitis (6, 10), direct proof is still missing due to the
lack of a suitable animal model. Why the activity has been conserved in
G. haemolysans along with the mentioned
Streptococcus species is an intriguing question.
 |
ACKNOWLEDGMENTS |
This study was supported by a grant from the Danish Medical
Research Council.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medical Microbiology and Immunology, The Bartholin Building, University of Aarhus, DK-8000 Aarhus C, Denmark. Phone: 458942 1735. Fax: 458619 6128. E-mail: kilian{at}microbiology.au.dk.
 |
REFERENCES |
| 1.
|
Berger, U.
1985.
Prevalence of Gemella haemolysans on the pharyngeal mucosa of man.
Med. Microbiol. Immunol.
174:267-274[CrossRef][Medline].
|
| 2.
|
Collins, M. D.,
R. A. Hutson,
E. Falsen,
B. Sjöden, and R. R. Facklam.
1998.
Gemella bergeriae sp. nov., isolated from human clinical specimens.
J. Clin. Microbiol.
36:1290-1293[Abstract/Free Full Text].
|
| 3.
|
Collins, M. D.,
R. A. Hutson,
E. Falsen,
B. Sjöden, and R. R. Facklam.
1998.
Description of Gemella sanguinis sp. nov., isolated from human clinical specimens.
J. Clin. Microbiol.
36:3090-3093[Abstract/Free Full Text].
|
| 4.
|
Facklam, R., and J. A. Elliott.
1995.
Identification, classification, and clinical relevance of catalase-negative, gram-positive cocci, excluding streptococci and enterococci.
Clin. Microbiol. Rev.
8:479-495[Abstract].
|
| 5.
|
Kilian, M.,
J. Mestecky,
R. Kulhavy,
M. Tomana, and W. T. Butler.
1980.
IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: comparative immunochemical studies.
J. Immunol.
124:2596-2600[Abstract].
|
| 6.
|
Kilian, M.,
J. Reinholdt,
H. Lomholt,
K. Poulsen, and E. V. G. Frandsen.
1996.
Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence.
APMIS
104:321-338[Medline].
|
| 7.
|
Kilian, M.,
B. Thomsen,
T. E. Petersen, and H. S. Bleeg.
1983.
Occurrence and nature of bacterial IgA proteases.
Ann. N. Y. Acad. Sci.
409:612-624[Medline].
|
| 8.
|
Kilian, M.,
L. Mikkelsen, and J. Henrichsen.
1989.
Taxonomic study of viridans streptococci: description of Streptococcus gordonii sp. nov. and emended descriptions of Streptococcus sanguis (White and Niven 1946), Streptococcus oralis (Bridge and Sneath 1982), and Streptococcus mitis (Andrewes and Horder 1906).
Int. J. Syst. Bacteriol.
39:471-484.
|
| 9.
| Mikkelsen, L., E. Theilade, and K. Poulsen.
Differentiation between Abiotrophia strains (former
nutritionally variant streptococci) and oral Streptococcus
species isolated from early dental plaque. Oral Microbiol. Immunol., in
press.
|
| 10.
|
Plaut, A. G.
1983.
The IgA proteases of pathogenic bacteria.
Annu. Rev. Microbiol.
37:603-622[CrossRef][Medline].
|
| 11.
|
Poulsen, K.,
J. Reinholdt,
C. Jespersgaard,
K. Boye,
T. A. Brown,
M. Hauge, and M. Kilian.
1998.
A comprehensive genetic study of streptococcal immunoglobulin A1 proteases: evidence of recombination within and between species.
Infect. Immun.
66:181-190[Abstract/Free Full Text].
|
| 12.
|
Whitney, A. M., and S. P. O'Connor.
1993.
Phylogenetic relationship of Gemella morbillorum and Gemella haemolysans.
Int. J. Syst. Bacteriol.
43:832-838[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, July 2000, p. 2760-2762, Vol. 38, No. 7
0095-1137/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Takenouchi-Ohkubo, N., Mortensen, L. M., Drasbek, K. R., Kilian, M., Poulsen, K.
(2006). Horizontal transfer of the immunoglobulin A1 protease gene (iga) from Streptococcus to Gemella haemolysans. Microbiology
152: 2171-2180
[Abstract]
[Full Text]